Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity
Standard
Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity. / Linecker, Michael; Björnsson, Bergthor; Stavrou, Gregor A; Oldhafer, Karl J; Lurje, Georg; Neumann, Ulf; Adam, René; Pruvot, Francois-René; Topp, Stefan A; Li, Jun; Capobianco, Ivan; Nadalin, Silvio; Machado, Marcel Autran; Voskanyan, Sergey; Balci, Deniz; Hernandez-Alejandro, Roberto; Alvarez, Fernando A; De Santibañes, Eduardo; Robles-Campos, Ricardo; Malagó, Massimo; de Oliveira, Michelle L; Lesurtel, Mickael; Clavien, Pierre-Alain; Petrowsky, Henrik.
In: ANN SURG, Vol. 266, No. 5, 11.2017, p. 779-786.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity
AU - Linecker, Michael
AU - Björnsson, Bergthor
AU - Stavrou, Gregor A
AU - Oldhafer, Karl J
AU - Lurje, Georg
AU - Neumann, Ulf
AU - Adam, René
AU - Pruvot, Francois-René
AU - Topp, Stefan A
AU - Li, Jun
AU - Capobianco, Ivan
AU - Nadalin, Silvio
AU - Machado, Marcel Autran
AU - Voskanyan, Sergey
AU - Balci, Deniz
AU - Hernandez-Alejandro, Roberto
AU - Alvarez, Fernando A
AU - De Santibañes, Eduardo
AU - Robles-Campos, Ricardo
AU - Malagó, Massimo
AU - de Oliveira, Michelle L
AU - Lesurtel, Mickael
AU - Clavien, Pierre-Alain
AU - Petrowsky, Henrik
PY - 2017/11
Y1 - 2017/11
N2 - OBJECTIVE: To longitudinally assess whether risk adjustment in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) occurred over time and is associated with postoperative outcome.BACKGROUND: ALPPS is a novel 2-stage hepatectomy enabling resection of extensive hepatic tumors. ALPPS has been criticized for its high mortality, which is reported beyond accepted standards in liver surgery. Therefore, adjustments in patient selection and technique have been performed but have not yet been studied over time in relation to outcome.METHODS: ALPPS centers of the International ALPPS Registry having performed ≥10 cases over a period of ≥3 years were assessed for 90-day mortality and major interstage complications (≥3b) of the longitudinal study period from 2009 to 2015. The predicted prestage 1 and 2 mortality risks were calculated for each patient. In addition, questionnaires were sent to all centers exploring center-specific risk adjustment strategies.RESULTS: Among 437 patients from 16 centers, a shift in indications toward colorectal liver metastases from 53% to 77% and a reverse trend in biliary tumors from 24% to 9% were observed. Over time, 90-day mortality decreased from initially 17% to 4% in 2015 (P = 0.002). Similarly, major interstage complications decreased from 10% to 3% (P = 0.011). The reduction of 90-day mortality was independently associated with a risk adjustment in patient selection (P < 0.001; OR: 1.62; 95% CI: 1.36-1.93) and using less invasive techniques in stage-1 surgery (P = 0.019; OR: 0.39; 95% CI: 0.18-0.86). A survey indicated risk adjustment of patient selection in all centers and ALPPS technique in the majority (80%) of centers.CONCLUSIONS: Risk adjustment of patient selection and technique in ALPPS resulted in a continuous drop of early mortality and major postoperative morbidity, which has meanwhile reached standard outcome measures accepted for major liver surgery.
AB - OBJECTIVE: To longitudinally assess whether risk adjustment in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) occurred over time and is associated with postoperative outcome.BACKGROUND: ALPPS is a novel 2-stage hepatectomy enabling resection of extensive hepatic tumors. ALPPS has been criticized for its high mortality, which is reported beyond accepted standards in liver surgery. Therefore, adjustments in patient selection and technique have been performed but have not yet been studied over time in relation to outcome.METHODS: ALPPS centers of the International ALPPS Registry having performed ≥10 cases over a period of ≥3 years were assessed for 90-day mortality and major interstage complications (≥3b) of the longitudinal study period from 2009 to 2015. The predicted prestage 1 and 2 mortality risks were calculated for each patient. In addition, questionnaires were sent to all centers exploring center-specific risk adjustment strategies.RESULTS: Among 437 patients from 16 centers, a shift in indications toward colorectal liver metastases from 53% to 77% and a reverse trend in biliary tumors from 24% to 9% were observed. Over time, 90-day mortality decreased from initially 17% to 4% in 2015 (P = 0.002). Similarly, major interstage complications decreased from 10% to 3% (P = 0.011). The reduction of 90-day mortality was independently associated with a risk adjustment in patient selection (P < 0.001; OR: 1.62; 95% CI: 1.36-1.93) and using less invasive techniques in stage-1 surgery (P = 0.019; OR: 0.39; 95% CI: 0.18-0.86). A survey indicated risk adjustment of patient selection in all centers and ALPPS technique in the majority (80%) of centers.CONCLUSIONS: Risk adjustment of patient selection and technique in ALPPS resulted in a continuous drop of early mortality and major postoperative morbidity, which has meanwhile reached standard outcome measures accepted for major liver surgery.
KW - Aged
KW - Colorectal Neoplasms
KW - Female
KW - Hepatectomy
KW - Humans
KW - Ligation
KW - Liver Neoplasms
KW - Logistic Models
KW - Longitudinal Studies
KW - Male
KW - Middle Aged
KW - Multivariate Analysis
KW - Patient Selection
KW - Portal Vein
KW - Postoperative Complications
KW - Registries
KW - Risk Adjustment
KW - Treatment Outcome
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
U2 - 10.1097/SLA.0000000000002446
DO - 10.1097/SLA.0000000000002446
M3 - SCORING: Journal article
C2 - 28806301
VL - 266
SP - 779
EP - 786
JO - ANN SURG
JF - ANN SURG
SN - 0003-4932
IS - 5
ER -